A client is scheduled for the first fingolimod dose. Which plan is appropriate?
1Administer the first dose at home after teaching the client to report dizziness, palpitations, or syncope by telephone.
2Obtain a baseline pulse and blood pressure, give the dose in clinic, and omit ECGs when no cardiac history is present.
3Monitor oxygen saturation and symptoms for 30 minutes, then discharge if the client remains asymptomatic.
4Obtain baseline cardiac assessment, then monitor pulse and blood pressure hourly for 6 hours with pre- and post-dose ECGs.✓ Correct answer
Explanation
Fingolimod can cause first-dose bradycardia and atrioventricular conduction delay. Required baseline assessment and at least 6 hours of observation with pulse and blood-pressure checks are part of safe initiation.
Quick answer Treat the first fingolimod dose as a monitored cardiac event.
Why this is correct Additional or overnight monitoring is required when post-dose findings meet labeled risk criteria.
Easy analogy or mental picture Build a medication-safety chain: identify the new cue, connect it to the drug mechanism or labeled limitation, stop preventable exposure, stabilize the client, and verify a measurable response.
Memory hook Drug, urgent cue, protective action, and reassessment endpoint.
NCLEX decision rule Choose the action that prevents the most immediate medication-related harm while preserving indicated treatment and required monitoring.
Why the other choices are wrong Options that continue a suspect exposure, normalize a labeled danger cue, substitute an unauthorized dose, or delay escalation leave the client at risk.
References
1DailyMed: GILENYA (fingolimod)First-dose bradycardia and observation requirements
Medication-safety reviewVerify indication, current assessment, dose and route, organ function, interactions, urgent toxicity cues, authorized action, and measurable follow-up.